Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular pathways and role of epigenetics in the idiopathic pulmonary fibrosis
Varalakshmi Velagacherla, Chetan Hasmukh Mehta, Yogendra Nayak, et al.
Life Sciences (2022) Vol. 291, pp. 120283-120283
Closed Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Network pharmacology and molecular docking combined with widely targeted metabolomics to elucidate the potential compounds and targets of Euphorbia helioscopia seeds for the treatment of pulmonary fibrosis
Yanxia Liu, Wanqing Sun, Na Shen, et al.
Computers in Biology and Medicine (2023) Vol. 160, pp. 107007-107007
Open Access | Times Cited: 23
The role of epithelial cells in fibrosis: Mechanisms and treatment
Liuyi Luo, Wei Zhang, Siyao You, et al.
Pharmacological Research (2024) Vol. 202, pp. 107144-107144
Open Access | Times Cited: 9
Highlights on Future Treatments of IPF: Clues and Pitfalls
Alessandro Libra, Enrico Sciacca, Giuseppe Muscato, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8392-8392
Open Access | Times Cited: 8
Network Pharmacology-driven therapeutic interventions for Interstitial Lung Diseases using Traditional medicines: A Narrative Review
Megh Pravin Vithalkar, K. Sandra, Bharath Harohalli Byregowda, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113979-113979
Open Access | Times Cited: 1
Epigenetic Targets and Their Inhibitors in the Treatment of Idiopathic Pulmonary Fibrosis
Xiaohui Miao, Pan Liu, Yangyang Liu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117463-117463
Closed Access | Times Cited: 1
The Genetic and Epigenetic Footprint in Idiopathic Pulmonary Fibrosis and Familial Pulmonary Fibrosis: A State-of-the-Art Review
Claudio Tirelli, Chiara Pesenti, Monica Miozzo, et al.
Diagnostics (2022) Vol. 12, Iss. 12, pp. 3107-3107
Open Access | Times Cited: 31
Macrophage Implication in IPF: Updates on Immune, Epigenetic, and Metabolic Pathways
Deepak Pokhreal, Bruno Crestani, Doumet Georges Helou
Cells (2023) Vol. 12, Iss. 17, pp. 2193-2193
Open Access | Times Cited: 18
Idiopathic Pulmonary Fibrosis: Where do We Stand and How Far to Go?
Vaishali Singh, Ilya V. Ulasov, Sachin Gupta, et al.
Discovery Medicine (2024) Vol. 36, Iss. 180, pp. 22-22
Open Access | Times Cited: 5
Role of transient receptor potential ankyrin 1 in idiopathic pulmonary fibrosis: modulation of M2 macrophage polarization
Yi Yang, Zhenyu Xiao, Weijie Yang, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 5
Thalidomide interaction with inflammation in idiopathic pulmonary fibrosis
Nikitha Naomi Dsouza, Varun Alampady, Krishnaprasad Baby, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 3, pp. 1167-1182
Open Access | Times Cited: 11
Favipiravir ameliorates bleomycin-induced pulmonary fibrosis by reprogramming M1/M2 macrophage polarization
Ruiqin Zhang, Qiuyan Jiang, Shaoyan Gao, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111774-111774
Closed Access | Times Cited: 4
DNA methylation modification in Idiopathic pulmonary fibrosis
Lu Ren, Yanfen Chang, Shi-He Jiang, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 4
Role of Epigenetics in Chronic Lung Disease
Felix Ritzmann, Michelle Brand, Robert Bals, et al.
Cells (2025) Vol. 14, Iss. 4, pp. 251-251
Open Access
Fabrication and Evaluation of Self-Assembled Folic Acid Surface Modified Nintedanib Mixed Micelles to Treat Idiopathic Pulmonary Fibrosis
Varalakshmi Velagacherla, Yogendra Nayak, Reema Narayan, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106801-106801
Closed Access
N-(2-Aminophenyl)-benzamide Inhibitors of Class I HDAC Enzymes with Antiproliferative and Antifibrotic Activity
Dimitrios Triantafyllos Gerokonstantis, Christiana Mantzourani, Dimitrios Gkikas, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 20, pp. 14357-14376
Closed Access | Times Cited: 8
Sp1-activated FGFR2 is involved in early-life exposure to nickel-induced craniosynostosis by regulating the ERK1/2 signaling pathway
Zhenkun Weng, Cheng Xu, Xiu Chen, et al.
Environment International (2024) Vol. 184, pp. 108477-108477
Open Access | Times Cited: 2
Inhibition of EGFR attenuates EGF-induced activation of retinal pigment epithelium cell via EGFR/AKT signaling pathway
Yu-Sheng Zhu, Hui-Hui Zhang, Tong Wang, et al.
International Journal of Ophthalmology (2024) Vol. 17, Iss. 6, pp. 1018-1027
Open Access | Times Cited: 2
Evaluation of Proteasome Inhibitors in the Treatment of Idiopathic Pulmonary Fibrosis
I‐Chen Chen, Yi‐Ching Liu, Yen-Hsien Wu, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1543-1543
Open Access | Times Cited: 9
Interference with connective tissue growth factor attenuated fibroblast-to-myofibroblast transition and pulmonary fibrosis
Zhizhou Yang, Mengmeng Wang, Liping Cao, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 10, pp. 566-566
Open Access | Times Cited: 8
Plasma genome-wide mendelian randomization identifies potentially causal genes in idiopathic pulmonary fibrosis
Kun Zhang, Puyu Shi, Anqi Li, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Mechanisms underlying the involvement of peritoneal macrophages in the pathogenesis and novel therapeutic strategies for dialysis-induced peritoneal fibrosis
Yangwei Wang, Yixian Zhang, Mingqi Ma, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
The role of eCIRP in bleomycin-induced pulmonary fibrosis in mice
Siavash Bolourani, Ezgi Sari, Max Brenner, et al.
PLoS ONE (2022) Vol. 17, Iss. 4, pp. e0266163-e0266163
Open Access | Times Cited: 6
LKB1 depletion-mediated epithelial–mesenchymal transition induces fibroblast activation in lung fibrosis
Zijian Xu, Elizabeth R. Davies, Liudi Yao, et al.
Genes & Diseases (2023) Vol. 11, Iss. 3, pp. 101065-101065
Open Access | Times Cited: 3
Association of family sequence similarity gene 13A gene polymorphism and interstitial lung disease susceptibility: A systematic review and meta‐analysis
Yinan Hu, Zhen Li, Yanhong Ren, et al.
Molecular Genetics & Genomic Medicine (2023) Vol. 11, Iss. 11
Open Access | Times Cited: 3
Immune mechanisms and novel therapies for idiopathic pulmonary fibrosis
Dongyang Gao, Wenli Gao, Zhiguang Zhai, et al.
Pharmaceutical Science Advances (2023) Vol. 2, pp. 100030-100030
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top